BIOLASE to Present at Upcoming Investment Conferences
IRVINE, CA, May 08, 2012 (Menafn - MARKETWIRE via COMTEX) --BIOLASE Technology, Inc. BLTI, the World's leading dentallaser manufacturer and distributor, today announced that managementis scheduled to make investor presentations at three upcominginvestment conferences.
The first conference will be Security Research Associates' 8th AnnualSpring Growth Stock Conference on Tuesday, May 15, during which CFOand COO Frederick Furry is scheduled to present at 2:30 pm PacificTime. The conference is being held at the Le Meridien Hotel in SanFrancisco. A live audio webcast of the presentation at thisconference will be available in the Investors section of the BIOLASEwebsite at www.biolase.com.
The second conference will be the 13th Annual B. Riley & Co. InvestorConference on Wednesday, May 23, during which CFO and COO FrederickFurry is scheduled to present at 2:00 pm Pacific Time. The conferenceis being held at the Loews Santa Monica Beach Hotel in Santa Monica,CA.
The third conference will be SunTrust Robinson Humphrey's AnnualVeterinary and Dental Conference on Wednesday, May 30, during whichChairman and CEO Federico Pignatelli is scheduled to host one-on-oneand small group meetings throughout the day. The conference is beingheld at the Le Meridien Hotel in New York City.
About BIOLASE Technology, Inc. BIOLASE Technology, Inc., the World'sleading Dental Laser Company, is a medical technology company thatdevelops, manufactures and markets dental lasers and also distributesand markets dental imaging equipment, products that are focused ontechnologies that advance the practice of dentistry and medicine. TheCompany's laser products incorporate 285 patented and patent pendingtechnologies designed to provide clinically superior performance withless pain and faster recovery times. Its imaging products providecutting-edge technology at competitive prices to deliver the bestresults for dentists and patients. BIOLASE's principal products aredental laser systems that perform a broad range of dental procedures,including cosmetic and complex surgical applications, and a full lineof dental imaging equipment. BIOLASE has sold more than 19,000 lasersamong 16,000 customers. Other products under development addressophthalmology and other medical and consumer markets.
For updates and information on laser and Waterlase dentistry, findBIOLASE at http://www.biolase.com, Twitter athttp://twitter.com/GoWaterlase, and YouTube athttp://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within themeaning of safe harbor provided by the Securities Reform Act of 1995that are based on the current expectations and estimates by BIOLASEmanagement. These forward-looking statements can be identifiedthrough the use of words such as "anticipates," "expects," "intends,""plans," "believes," "seeks," "estimates," "may," "will," andvariations of these words or similar expressions. Forward-lookingstatements are based on management's current, preliminaryexpectations and are subject to risks, uncertainties and otherfactors which may cause the Company's actual results to differmaterially from the statements contained herein, and are described inthe Company's reports it files with the Securities and ExchangeCommission, including its annual and quarterly reports. No unduereliance should be placed on forward-looking statements. Suchinformation is subject to change, and BIOLASE undertakes noobligation to update such statements.
For further information, please contact:
Allen & Caron
SOURCE: BIOLASE Technology, Inc.
Copyright 2012 Marketwire, Inc., All rights reserved.